Stay updated on Pembrolizumab for ALL MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record is displayed with its treatment plan, eligibility criteria, outcomes, and related documents. It identifies the pembrolizumab trial as terminated due to lack of efficacy and no longer recruiting participants.
    Difference
    54%
    Check dated 2026-11-07T11:46:47.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:13:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:10:33.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the study page remains an error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:11:26.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T12:54:55.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the expected study record content, with the header and footer still visible. This indicates restricted access or an unavailable page rather than updated trial information.
    Difference
    19%
    Check dated 2026-09-19T22:14:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.